Werter, Inge M. http://orcid.org/0000-0002-4411-0450
,
Huijts, Charlotte M.
Lougheed, Sinéad. M.
Hamberg, Paul
Polee, Marco B.
Tascilar, Metin
Los, Maartje
Haanen, John B. A. G.
Helgason, Helgi H.
Verheul, Henk M.
de Gruijl, Tanja D.
van der Vliet, Hans J.
Funding for this research was provided by:
KWF Kankerbestrijding (VU 2011-5144)
Novartis Oncology Netherlands (.)
Article History
Received: 22 September 2018
Accepted: 2 February 2019
First Online: 11 February 2019
Compliance with ethical standards
:
: The authors declare that they have no competing interests.
: The study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and are consistent with International Conference on Harmonization (ICH) Guidelines for Good Clinical Practice. The Medical Ethical Committee of the VU University Medical Center, Amsterdam, the Netherlands (METC, 2011/16) and the Central Committee on Research Involving Human Subjects (CCMO, NL35150.029.11) approved the study protocol.
: All individual patients gave written informed consent to the use of their blood and data in this study prior to start of treatment.